PacBio Files Q3 2024 10-Q with Revenue Details
Ticker: PACB · Form: 10-Q · Filed: 2024-11-12T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, revenue
Related Tickers: PACB
TL;DR
PACB 10-Q filed: Q3 revenue numbers in, check financials.
AI Summary
Pacific Biosciences of California, Inc. (PACB) filed its 10-Q for the period ending September 30, 2024. The company reported revenue for the third quarter of 2024 and year-to-date, with specific figures for product and service/other revenue segments. Financial details regarding common stock and other equity components as of June 30, 2024, were also disclosed.
Why It Matters
This filing provides investors with the latest financial performance data for Pacific Biosciences, crucial for understanding the company's revenue generation and financial health in the third quarter of 2024.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing (10-Q) and does not contain immediate, high-impact news.
Key Numbers
- 2024-09-30 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 2024-11-12 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (company) — Filer of the 10-Q
- 20240930 (date) — End of the reporting period
- 20241112 (date) — Filing date
- 1305 O'BRIEN DRIVE MENLO PARK CA 94025 (address) — Company's business and mailing address
FAQ
What were Pacific Biosciences' total revenues for the third quarter of 2024?
The filing indicates revenue data for the period 2024-07-01 to 2024-09-30, but specific total revenue figures are not explicitly stated in the provided header information.
What is the company's primary industry classification?
Pacific Biosciences of California, Inc. is classified under 'LABORATORY ANALYTICAL INSTRUMENTS' with SIC code 3826.
When is Pacific Biosciences' fiscal year end?
The company's fiscal year ends on December 31 (1231).
What is the SEC file number for this company?
The SEC file number for Pacific Biosciences of California, Inc. is 001-34899.
What was the company's address as listed in the filing?
The company's business and mailing address is 1305 O'BRIEN DRIVE, MENLO PARK, CA 94025.
From the Filing
0001299130-24-000183.txt : 20241112 0001299130-24-000183.hdr.sgml : 20241112 20241108192841 ACCESSION NUMBER: 0001299130-24-000183 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 79 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 241442515 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 10-Q 1 pacb-20240930.htm 10-Q pacb-20240930 0001299130 12-31 2024 Q3 false P20D 0.0229885 0.0465116 0.2045157 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure utr:D 0001299130 2024-01-01 2024-09-30 0001299130 2024-10-31 0001299130 2024-09-30 0001299130 2023-12-31 0001299130 us-gaap:ProductMember 2024-07-01 2024-09-30 0001299130 us-gaap:ProductMember 2023-07-01 2023-09-30 0001299130 us-gaap:ProductMember 2024-01-01 2024-09-30 0001299130 us-gaap:ProductMember 2023-01-01 2023-09-30 0001299130 pacb:ServiceAndOtherMember 2024-07-01 2024-09-30 0001299130 pacb:ServiceAndOtherMember 2023-07-01 2023-09-30 0001299130 pacb:ServiceAndOtherMember 2024-01-01 2024-09-30 0001299130 pacb:ServiceAndOtherMember 2023-01-01 2023-09-30 0001299130 2024-07-01 2024-09-30 0001299130 2023-07-01 2023-09-30 0001299130 2023-01-01 2023-09-30 0001299130 us-gaap:CommonStockMember 2024-06-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001299130 us-gaap:RetainedEarningsMember 2024-06-30 0001299130 2024-06-30 0001299130 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001299130 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001299130 us-gaap:CommonStockMember 2024-09-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001299130 us-gaap:RetainedEarningsMember 2024-09-30 0001299130 us-gaap:CommonStockMember 2023-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001299130 us-gaap:RetainedEarningsMember 2023-12-31 0001299130 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0001299130 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001299130 us-gaap:CommonStockMember 2023-06-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001299130 us-gaap:RetainedEarningsMember 2023-06-30 0001299130 2023-06-30 0001299130 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001299130 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001299130 us-gaap:CommonStockMember 2023-09-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001299130 us-gaap:RetainedEarningsMember 2023-09-30 0001299130 2023-09-30 0001299130 us